Regulatory affairs in pharma is the function responsible for getting drugs approved and keeping them compliant in every market — from clinical trial permissions and marketing authorisation to labelling, variations, renewals, and post-market safety reporting. Regulatory affairs professionals prepare and submit dossiers to health authorities such as India's CDSCO, the US FDA, and the EMA, and act as the bridge between R&D, quality, manufacturing, and the regulator. It is a core, non-optional function in every pharmaceutical company, CRO, and consultancy.

In clinical research, regulatory affairs handles everything needed to start and run a trial legally — preparing and filing clinical trial applications and INDs with authorities such as the CDSCO in India or the US FDA, securing ethics approvals, managing protocol amendments, safety reporting, and inspection readiness. The role ensures a trial remains compliant from the first submission to the final study report.

Medical device regulatory affairs is the specialty focused on getting devices legally marketed and keeping them compliant across their lifecycle. It covers device classification, US FDA pathways (510(k), De Novo, PMA), CE marking under the EU MDR, quality systems aligned with ISO 13485, risk management under ISO 14971, and post-market surveillance and vigilance. Because devices range from simple disposables to AI-driven software, requirements vary sharply by risk class and market.

Start with a relevant base — pharmacy, biomedical engineering, life sciences, dentistry, or medicine all transition well. Next, build knowledge of the FDA's device pathways (especially the 510(k)), the EU MDR, and standards like ISO 13485 and ISO 14971 through certificate courses or a master's in regulatory affairs. Since direct fresher openings are limited, many people enter through quality assurance, clinical, or documentation roles and shift internally. Clinicians have a real edge in understanding device use and clinical evidence.

The usual path is a pharmacy, life-sciences, or biomedical degree followed by an entry role such as regulatory affairs associate or executive, where you learn dossier preparation, submissions, and authority interactions. Add structured learning — a regulatory affairs certificate or diploma, or RAPS RAC later in your career — and master one segment deeply, either drugs or medical devices. Strong scientific writing and attention to detail matter as much as regulatory knowledge, and most people grow into a specialist title after a few years of hands-on submission experience.

A regulatory affairs manager is typically a specialist or senior executive promoted after leading submissions end to end. To get there, focus on independently owning dossiers (ANDAs, 510(k)s, or CE technical documentation), managing authority interactions, understanding multiple markets such as India, the US, and the EU, and building project and team management skills. Credentials like RAC and exposure to evolving areas — biologics, combination products, and AI/ML-based software — accelerate the move into management.

Common entry titles include regulatory affairs officer, regulatory affairs associate or executive, and junior regulatory documentation roles across pharma companies, CROs, and medical device firms. Hiring is concentrated in hubs like Hyderabad, Mumbai, Pune, Ahmedabad, and Bengaluru. Freshers with a B.Pharm, M.Pharm, or life-sciences degree stand out by knowing the Drugs and Cosmetics Act, CDSCO processes, and ICH-GCP basics, and by having completed an internship or project in a regulatory topic.

Yes — demand keeps rising as Indian pharma expands globally, medical device regulation tightens, and newer areas like biosimilars, wearables, and AI-based software create fresh compliance needs. Openings exist across pharma manufacturers, CROs, medtech startups, consultancies, and global capability centres handling US and EU markets. Candidates who pair regulatory knowledge with modern tools, including AI-based documentation, have a visible advantage.

Prefer courses that teach actual submission work rather than only theory: postgraduate diplomas and certificates in regulatory affairs from Indian universities, RAPS's RAC certification (better after some work experience), and device-focused programs covering the EU MDR, FDA 510(k), and ISO 13485. A full master's in regulatory affairs, in India or abroad, suits those targeting global roles. Always check that the syllabus is updated to current regulations before enrolling.

Target pharma companies, CROs, and medtech firms in hubs like Hyderabad, Mumbai, and Pune through LinkedIn, Internshala, and company career pages — and don't hesitate to cold-email regulatory managers with a short, specific pitch. Joining bodies like RAPS (student membership), ISPE, or PDA and attending their events helps you hear about openings early. Even quality assurance or regulatory documentation internships count as a stepping stone into the field.

The Medical Device Rules, 2017 (MDR 2017) are the foundation of medical device regulation in India, issued under the Drugs and Cosmetics Act and administered by the CDSCO. They classify devices by risk into Classes A–D, require manufacturing and import licences through the CDSCO's online SUGAM portal, align quality systems with ISO 13485, and mandate post-market surveillance. They replaced the earlier setup where devices were regulated only as "drugs," bringing India closer to US FDA and EU MDR-style oversight.

FDA 510(k) clearance is the US FDA's confirmation that a new device is "substantially equivalent" to a legally marketed predicate device, allowing it to be marketed in the US. Most Class II devices reach the market through this route. The manufacturer files a 510(k) with the device description, bench and performance testing, and a point-by-point comparison to the predicate, and the FDA typically responds within around 90 days. Note the terminology: devices are "cleared" via 510(k), while high-risk Class III devices are "approved" via PMA.

An FDA 510(k) submission is the premarket notification a manufacturer files with the FDA to demonstrate that a device (usually Class II) is as safe and effective as an existing predicate. A typical package includes indications for use, device description, a comparison table against the predicate, bench testing, biocompatibility and sterility data, and software documentation where applicable. Before drafting one, teams use the FDA 510(k) database to shortlist a suitable predicate and study how similar devices were cleared.

It's a well-trodden path, because dentists bring clinical judgement, patient-safety thinking, and documentation discipline — all central to regulatory work. The usual route is to learn the frameworks (CDSCO's Medical Device Rules, FDA 510(k), EU MDR, ISO 13485 and 14971) through certificate courses or a master's in regulatory affairs, reposition your resume around transferable clinical skills, and target medical device and dental-product companies where clinical knowledge is an asset. Former clinicians often enter as regulatory affairs associates and progress quickly because they understand clinical evidence.

Anchor your preparation to the BDS syllabus: build a subject-wise plan covering clinical, para-clinical, and pre-clinical subjects, revise from standard textbooks using your own short notes, and solve previous years' question papers to spot recurring topics. Take full-length mock tests regularly to build MCQ speed and maintain an error log to close weak areas. In the final stretch, prioritise high-yield clinical subjects and case-based questions rather than starting new resources.